User menu

Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB(1) receptor

Bibliographic reference Bosier, Barbara ; Hermans, Emmanuel ; Lambert, Didier. Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB(1) receptor. In: British Journal of Pharmacology, Vol. 155, no. 1, p. 24-33 (2008)
Permanent URL http://hdl.handle.net/2078.1/12700
  1. Alexander, Br J Pharmacol, 153, S1 (2008)
  2. Bash, Neurosignals, 12, 39 (2003)
  3. Bonhaus, J Pharmacol Exp Ther, 287, 884 (1998)
  4. Bosier, Trends Pharmacol Sci, 28, 438 (2007)
  5. Bosier, J Neurochem, 102, 1996 (2007)
  6. Bouaboula M, Poinot-Chazel C, Bourrié B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G, Casellas P, Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1, 10.1042/bj3120637
  7. Calandra, Eur J Pharmacol, 374, 445 (1999)
  8. Casu, Brain Res, 1048, 41 (2005)
  9. Condie, J Biol Chem, 271, 13175 (1996)
  10. Faubert, J Leukoc Biol, 67, 259 (2000)
  11. Giuliano, Int J Mol Med, 17, 811 (2006)
  12. Glass, J Neurosci, 17, 5327 (1997)
  13. Glass, Mol Pharmacol, 56, 1362 (1999)
  14. Hampson, J Neurophysiol, 84, 2356 (2000)
  15. Herring, Cell Signal, 13, 241 (2001)
  16. Herring, Biochem Pharmacol, 55, 1013 (1998)
  17. Ho, Receptors Channels, 6, 363 (1999)
  18. Jarrahian, J Pharmacol Exp Ther, 308, 880 (2004)
  19. Kim, Proc Natl Acad Sci USA, 90, 3471 (1993)
  20. Koh, Biochem Pharmacol, 53, 1477 (1997)
  21. Lauckner, Proc Natl Acad Sci USA, 102, 19144 (2005)
  22. Lewis-Tuffin, Mol Cell Neurosci, 25, 536 (2004)
  23. Maccarrone, J Biol Chem, 278, 33896 (2003)
  24. Mackie, Proc Natl Acad Sci USA, 89, 3825 (1992)
  25. Mackie, J Neurosci, 15, 6552 (1995)
  26. Maneuf, Br J Pharmacol, 120, 1397 (1997)
  27. McIntosh, Br J Pharmacol, 152, 1111 (2007)
  28. Mukhopadhyay, Mol Pharmacol, 67, 2016 (2005)
  29. Murphy, Biochem Pharmacol, 38, 3289 (1989)
  30. Najimi, Mol Pharmacol, 62, 647 (2002)
  31. Ouyang, Mol Pharmacol, 53, 676 (1998)
  32. Pertwee, Curr Med Chem, 6, 635 (1999)
  33. Pierreux, Mol Endocrinol, 12, 1343 (1998)
  34. Porcella, Eur J Neurosci, 10, 1743 (1998)
  35. Prather, Mol Pharmacol, 57, 1000 (2000)
  36. Rubino, Neuropsychopharmacology, 32, 2036 (2007)
  37. Rubovitch, Brain Res Mol Brain Res, 101, 93 (2002)
  38. Rueda, Mol Pharmacol, 58, 814 (2000)
  39. Stenstrom, Biochem Pharmacol, 34, 3655 (1985)
  40. Sugiura T., Kodaka T., Kondo S., Nakane S., Kondo H., Waku K., Ishima Y., Watanabe K., Yamamoto I., Is the Cannabinoid CB1 Receptor a 2-Arachidonoylglycerol Receptor? Structural Requirements for Triggering a Ca2+ Transient in NG108-15 Cells, 10.1093/oxfordjournals.jbchem.a021838
  41. Sugiura, Biochem Biophys Res Commun, 229, 58 (1996)
  42. Zhao, J Biol Chem, 280, 26735 (2005)